Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups

BACKGROUND: Interleukin 6 (IL-6) signaling is being investigated as a therapeutic target for atherosclerotic cardiovascular disease (CVD). While changes in circulating high-sensitivity C-reactive protein (hsCRP) are used as a marker of IL-6 signaling, it is not known whether there is effect heteroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgakis, Marios K., Malik, Rainer, Richardson, Tom G., Howson, Joanna M. M., Anderson, Christopher D., Burgess, Stephen, Hovingh, G. Kees, Dichgans, Martin, Gill, Dipender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367072/
https://www.ncbi.nlm.nih.gov/pubmed/35948913
http://dx.doi.org/10.1186/s12916-022-02446-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367072/
https://www.ncbi.nlm.nih.gov/pubmed/35948913
http://dx.doi.org/10.1186/s12916-022-02446-6

Ejemplares similares